Ranjeev Krishana
Direktor/Vorstandsmitglied bei BEIGENE, LTD.
Vermögen: 408 508 $ am 30.04.2024
Aktive Positionen von Ranjeev Krishana
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BEIGENE, LTD. | Direktor/Vorstandsmitglied | 01.10.2014 | - |
Independent Dir/Board Member | 01.10.2014 | - | |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Ranjeev Krishana
Ehemalige bekannte Positionen von Ranjeev Krishana
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01.04.2011 | 01.04.2011 |
PFIZER, INC. | Corporate Officer/Principal | 01.01.2007 | 01.01.2007 |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Corporate Officer/Principal | 01.01.2001 | 01.01.2001 |
Andersen Consulting (Minnesota) | Corporate Officer/Principal | 01.01.1997 | 01.01.1997 |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Portfolio Manager-Aktien | - | - |
Ausbildung von Ranjeev Krishana
Brown University | Undergraduate Degree |
Harvard University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Cayman Islands | 2 |
China | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
BEIGENE, LTD. | Health Technology |
Private Unternehmen | 4 |
---|---|
Andersen Consulting (Minnesota) | |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Commercial Services |
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Börse
- Insiders
- Ranjeev Krishana
- Erfahrung